Aducanumab, Accelerated Approvals & the Agency: Why the FDA Needs Structural Reform

Matthew Herder (Dalhousie University), Aducanumab, Accelerated Approvals& the Agency: Why the FDA Needs Structural Reform, J. L. Med.& Ethics (Forthcoming): The US Food and Drug Administration ’s controversial decision to grant accelerated approval to aducanumab (Aduhelm), a therapy for...

Source: HealthLawProf Blog - February 5, 2023 Category: Medical Law Authors: Katharine Van Tassel Source Type: blogs